Annual Drug Patent Expirations for TEFLARO
Teflaro is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TEFLARO.
This drug has sixty-five patent family members in thirty-four countries.
The generic ingredient in TEFLARO is ceftaroline fosamil. One supplier is listed for this compound. Additional details are available on the ceftaroline fosamil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
